Published online Nov 26, 2021. doi: 10.4330/wjc.v13.i11.628
Peer-review started: March 18, 2021
First decision: July 8, 2021
Revised: July 19, 2021
Accepted: October 27, 2021
Article in press: October 27, 2021
Published online: November 26, 2021
Processing time: 251 Days and 8.1 Hours
Cardiac masses diagnosis and treatment are a true challenge, although they are infrequently encountered in clinical practice. They encompass a broad set of lesions that include neoplastic (primary and secondary), non-neoplastic masses and pseudomasses. The clinical presentation of cardiac tumors is highly variable and depends on several factors such as size, location, relation with other structures and mobility. The presumptive diagnosis is made based on a pre
Core Tip: Cardiovascular magnetic resonance (CMR) allows an optimal non-invasive localization of cardiac masses by providing multiplanar information on its relation to the surrounding structures. Moreover, CMR can be highly effective to distinguish pseudomasses from masses as well as benign from malignant masses. Although histopathological assessment sometimes has an important role to make a definitive diagnosis, CMR is a key modality in the diagnosis of suspected cardiac masses with a great impact on patient management.